Literature DB >> 16373349

3-O-sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3.

Gerdy B Ten Dam1, Sindhulakshmi Kurup, Els M A van de Westerlo, Elly M M Versteeg, Ulf Lindahl, Dorothe Spillmann, Toin H van Kuppevelt.   

Abstract

Antibodies against heparan sulfate (HS) are useful tools to study the structural diversity of HS. They demonstrate the large sequential variation within HS and show the distribution of HS oligosaccharide sequences within their natural environment. We analyzed the distribution and the structural characteristics of the oligosaccharide epitope recognized by anti-HS antibody HS4C3. Biosynthetic and synthetic heparin-related oligosaccharide libraries were used in affinity chromatography, immunoprecipitation, and enzyme-linked immunosorbent assay to identify this epitope as a 3-O-sulfated motif with antithrombin binding capacity. The antibody binds weakly to any N-sulfated, 2-O- and 6-O-sulfated hexa- to octasaccharide fragment but strongly to the corresponding oligosaccharide when there is a 3-O-sulfated glucosamine residue present in the sequence. This difference was highlighted by affinity interaction and immunohistochemistry at salt concentrations from 500 mm. At physiological salt conditions the antibody strongly recognized basal lamina of epithelia and endothelia. At 500 mm salt conditions, when 3-O sulfation is required for binding, antibody recognition was more restricted and selective. Antibody HS4C3 bound similar tissue structures as antithrombin in rat kidney. Furthermore, antithrombin and antibody HS4C3 could compete with one another for binding to heparin. Antibody HS4C3 was also able to inhibit the anti-coagulant activities of heparin and Arixtra as demonstrated using the activated partial thromboplastin time clotting and the anti-factor Xa assays. In summary, antibody HS4C3 selectively detects 3-O-sulfated HS structures and interferes with the coagulation activities of heparin by association with the anti-thrombin binding pentasaccharide sequence.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16373349     DOI: 10.1074/jbc.M506357200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  Hitting the sweet spot.

Authors:  Gauri Kulkarni; William G Wadsworth
Journal:  Nat Methods       Date:  2012-04-27       Impact factor: 28.547

Review 2.  Proteoglycans in host-pathogen interactions: molecular mechanisms and therapeutic implications.

Authors:  Allison H Bartlett; Pyong Woo Park
Journal:  Expert Rev Mol Med       Date:  2010-02-01       Impact factor: 5.600

3.  HS3ST2 expression is critical for the abnormal phosphorylation of tau in Alzheimer's disease-related tau pathology.

Authors:  Julia Elisa Sepulveda-Diaz; Seyedeh Maryam Alavi Naini; Minh Bao Huynh; Mohand Ouidir Ouidja; Constantin Yanicostas; Sandrine Chantepie; Joao Villares; Foudil Lamari; Estelle Jospin; Toin H van Kuppevelt; Ayikoe Guy Mensah-Nyagan; Rita Raisman-Vozari; Nadia Soussi-Yanicostas; Dulce Papy-Garcia
Journal:  Brain       Date:  2015-04-04       Impact factor: 13.501

4.  Role of 3-O-sulfated heparan sulfate in virus-induced polykaryocyte formation.

Authors:  Vaibhav Tiwari; Gerdy B ten Dam; Beatrice Y J T Yue; Toin H van Kuppevelt; Deepak Shukla
Journal:  FEBS Lett       Date:  2007-08-24       Impact factor: 4.124

5.  Characterization and Quantification of Highly Sulfated Glycosaminoglycan Isomers by Gated-Trapped Ion Mobility Spectrometry Negative Electron Transfer Dissociation MS/MS.

Authors:  Juan Wei; Jiandong Wu; Yang Tang; Mark E Ridgeway; Melvin A Park; Catherine E Costello; Joseph Zaia; Cheng Lin
Journal:  Anal Chem       Date:  2019-01-31       Impact factor: 6.986

6.  Antibody GD3G7 selected against embryonic glycosaminoglycans defines chondroitin sulfate-E domains highly up-regulated in ovarian cancer and involved in vascular endothelial growth factor binding.

Authors:  Gerdy B ten Dam; Els M A van de Westerlo; Anurag Purushothaman; Radu V Stan; Johan Bulten; Fred C G J Sweep; Leon F Massuger; Kazuyuki Sugahara; Toin H van Kuppevelt
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

7.  A chemokine self-presentation mechanism involving formation of endothelial surface microstructures.

Authors:  Catherine Whittall; Oksana Kehoe; Sophie King; Antal Rot; Angela Patterson; Jim Middleton
Journal:  J Immunol       Date:  2013-01-16       Impact factor: 5.422

8.  Expanding the role of 3-O sulfated heparan sulfate in herpes simplex virus type-1 entry.

Authors:  Christopher D O'Donnell; Maria Kovacs; Jihan Akhtar; Tibor Valyi-Nagy; Deepak Shukla
Journal:  Virology       Date:  2009-12-11       Impact factor: 3.616

9.  Heparan sulfate phage display antibodies identify distinct epitopes with complex binding characteristics: insights into protein binding specificities.

Authors:  Sophie M Thompson; David G Fernig; Edwin C Jesudason; Paul D Losty; Els M A van de Westerlo; Toin H van Kuppevelt; Jeremy E Turnbull
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

10.  Synthesis of heparan sulfate with cyclophilin B-binding properties is determined by cell type-specific expression of sulfotransferases.

Authors:  Audrey Deligny; Agnès Denys; Adeline Marcant; Aurélie Melchior; Joël Mazurier; Toin H van Kuppevelt; Fabrice Allain
Journal:  J Biol Chem       Date:  2009-11-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.